article thumbnail

[UPCKat] Access to confidential information by parties and the public in the UPC

The IPKat

The UPCKat trying to keep confidential information confidential in the UPC As part of our UPCKat reporting on the latest UPC developments, the IPKat brings readers a roundup of how the UPC is treating confidentiality and third party access to court documents.

article thumbnail

Biosimilar Maker Leverages IPR to Avoid Patent Dance and Obtain Early Market Entry

Bio Law Blog

On May 28, Alexion and Amgen entered into a confidential settlement agreement to terminate the IPRs. Pursuant to the terms of the settlement agreement, effective March 1, 2025 (or earlier in certain circumstances), Alexion grants to Amgen a nonexclusive, royalty-free license under U.S. an eculizumab product.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Huawei and Verizon Settle Their Battle

IP and Legal Filings

Huawei and Verizon settle their FRAND patent dispute concerning the infringement claims in Texas, which was done shortly after the start of the trial. Through the settlementwhich was under confidential terms, the parties settle their patent dispute and lawsuits. Image Source: gettyimages].

article thumbnail

Methods of Commercializing Intellectual Property – Part I

Intepat

Things to Keep in Mind Maintaining Secrecy – Only inventions and designs which are not previously disclosed can be registered for patents and industrial designs. Therefore, it is important to make sure such confidential information is not publicised unauthorisedly.

article thumbnail

Has the Court of Appeal signalled the end of English judicial influence of Arrow declarations?

The IPKat

They sought an Arrow declaration that the importation, disposal, use and keeping by them of generic fingolimod in the UK for that specific use would have been obvious at the priority date of the patent in question ([5]). In this way the court can decide a patent infringement case even before the patent has been granted ([17]).

article thumbnail

SpicyIP Weekly Review (March 18- March 24)

SpicyIP

Zydus Lifesciences Limited, on 13 March 2024 (Delhi High Court ) The case centered on the establishment of a confidentiality club in a biosimilar litigation dispute. The court, emphasizing the need to preserve timelines and avoid prejudice, directed the Defendant to file a reply to the application within one week.

article thumbnail

SpicyIP Weekly Review (March 4-March 10)

SpicyIP

The Court sets aside the rejection, staying the suit until the rectification application’s disposal within eight months. Ynsect vs The Controller Of Patents on 28 February, 2024 (Delhi High Court) Image from here The appeal challenged the denial of an Indian patent application for insect treatment.